Brandon Couillard Analyst Performance

Managing Director, Life Science Tools & Diagnostics Equity Research Analyst at Wells Fargo & Company

Brandon Couillard is a stock analyst at Wells Fargo & Company focused in the medical sector, covering 25 publicly traded companies. Over the past year, Brandon Couillard has issued 35 stock ratings, including buy, hold, and sell recommendations. While full access to Brandon Couillard's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brandon Couillard's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 65 Last 10 Years
Buy Recommendations: 59.38% 38 Buy Ratings
Companies Covered: 25 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	59.4%	38 ratings
Hold	39.1%	25 ratings
Sell	1.6%	1 ratings

Out of 64 total stock ratings issued by Brandon Couillard at Wells Fargo & Company, the majority (59.4%) have been Buy recommendations, followed by 39.1% Hold and 1.6% Sell.

Best & Worst Calls

Best Call
0000.0%
EXAS
May 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
EXAS
May 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	64.0% of companies on NASDAQ	16 companies
NYSE	36.0% of companies on NYSE	9 companies

Brandon Couillard, an analyst at Wells Fargo & Company, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 23 companies	92.0%
	Computer and Technology 2 companies	8.0%

Brandon Couillard of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

Industry	Percentage
MEDICAL SERVICES 6 companies	24.0%
MED - BIOMED/GENE 5 companies	20.0%
MED INSTRUMENTS 5 companies	20.0%
MED PRODUCTS 3 companies	12.0%
MED/DENTAL - SUPP 2 companies	8.0%
INSTRU - SCIENTFC 1 company	4.0%
DENTAL EQUIPMENT & SUPPLIES 1 company	4.0%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	4.0%
ELEC MSRNG INST 1 company	4.0%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
NTRA Natera	9/22/2025	Initiated Coverage	$181.11	$175.00	Equal Weight
GH Guardant Health	9/22/2025	Initiated Coverage	$59.15	$72.00	Overweight
GH Guardant Health	9/22/2025	Initiated Coverage	$59.78	$72.00	Overweight
NTRA Natera	9/22/2025	Initiated Coverage	$179.19	$175.00	Equal Weight
A Agilent Technologies	9/15/2025	Boost Price Target	$123.19	$150.00	Overweight
A Agilent Technologies	8/28/2025	Boost Price Target	$122.64	$140.00	Overweight
CDNA CareDx	8/8/2025	Lower Price Target	$12.01	$14.00	Equal Weight
MLAB Mesa Laboratories	8/7/2025	Upgrade	$62.01	$67.00	Equal Weight
WAT Waters	8/5/2025	Lower Price Target	$282.64	$315.00	Equal Weight
BRKR Bruker	8/5/2025	Lower Price Target	$33.31	$50.00	Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AVTR Avantor	8/4/2025	Lower Price Target	$11.46	$16.00	Overweight
BRKR Bruker	8/4/2025	Set Price Target	$34.72	$60.00	Buy
BIO Bio-Rad Laboratories	8/1/2025	Boost Price Target	$287.26	$265.00	Equal Weight
RGEN Repligen	7/30/2025	Lower Price Target	$125.03	$175.00	Overweight
WGS GeneDx	7/30/2025	Boost Price Target	$99.01	$95.00	Equal Weight
TMO Thermo Fisher Scientific	7/24/2025	Lower Price Target	$479.89	$565.00	Overweight
DHR Danaher	7/23/2025	Lower Price Target	$196.53	$205.00	Equal Weight
WAT Waters	7/15/2025	Downgrade	$303.93	$330.00	Hold
BIO Bio-Rad Laboratories	6/9/2025	Lower Price Target	$228.26	$245.00	Equal Weight
TECH Bio-Techne	5/30/2025	Initiated Coverage	$48.33	$59.00	Overweight
MLAB Mesa Laboratories	5/30/2025	Lower Price Target	$102.35	$100.00	Underweight
MYGN Myriad Genetics	5/7/2025	Downgrade	$7.28	$6.00	Equal Weight
MTD Mettler-Toledo International	5/5/2025	Boost Price Target	$1,103.95	$1,200.00	Equal Weight
WGS GeneDx	5/1/2025	Lower Price Target	$64.64	$78.00	Equal Weight
TMO Thermo Fisher Scientific	4/24/2025	Lower Price Target	$432.31	$570.00	Overweight
A Agilent Technologies	4/21/2025	Lower Price Target	$99.62	$116.00	Hold
A Agilent Technologies	4/17/2025	Lower Price Target	$102.59	$135.00	Overweight
TMO Thermo Fisher Scientific	4/17/2025	Lower Price Target	$432.77	$580.00	Overweight
RVTY Revvity	4/17/2025	Lower Price Target	$92.75	$102.00	Equal Weight
MTD Mettler-Toledo International	4/17/2025	Lower Price Target	$1,011.15	$1,125.00	Equal Weight
BRKR Bruker	4/17/2025	Lower Price Target	$36.46	$60.00	Overweight
BIO Bio-Rad Laboratories	4/17/2025	Lower Price Target	$239.04	$270.00	Equal Weight
AVTR Avantor	4/17/2025	Lower Price Target	$15.12	$22.00	Overweight
ALGN Align Technology	1/23/2025	Lower Price Target	$233.07	$260.00	Buy
HSIC Henry Schein	1/23/2025	Boost Price Target	$74.09	$80.00	Hold

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.